Cargando…

Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study

OBJECTIVES: To elucidate the risk of cardiovascular event occurrence following Streptococcus pneumoniae infection. DESIGN: Retrospective cohort study using a LIFE Study database. SETTING: Three municipalities in Japan. PARTICIPANTS: Municipality residents who were enrolled in either National Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Naoaki, Fukuda, Haruhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639073/
https://www.ncbi.nlm.nih.gov/pubmed/36332949
http://dx.doi.org/10.1136/bmjopen-2021-059713
_version_ 1784825558114238464
author Nishimura, Naoaki
Fukuda, Haruhisa
author_facet Nishimura, Naoaki
Fukuda, Haruhisa
author_sort Nishimura, Naoaki
collection PubMed
description OBJECTIVES: To elucidate the risk of cardiovascular event occurrence following Streptococcus pneumoniae infection. DESIGN: Retrospective cohort study using a LIFE Study database. SETTING: Three municipalities in Japan. PARTICIPANTS: Municipality residents who were enrolled in either National Health Insurance or the Latter-Stage Elderly Healthcare System from April 2014 to March 2020. EXPOSURE: Occurrence of S. pneumoniae infection. PRIMARY OUTCOME MEASURES: Occurrence of one of the following cardiovascular events that led to hospitalisation after S. pneumoniae infection: (1) coronary heart disease (CHD), (2) heart failure (HF), (3) stroke or (4) atrial fibrillation (AF). RESULTS: S. pneumoniae-infected patients were matched with non-infected patients for each cardiovascular event. We matched 209 infected patients and 43 499 non-infected patients for CHD, 179 infected patients and 44 148 non-infected patients for HF, 221 infected patients and 44 768 non-infected patients for stroke, and 241 infected patients and 39 568 non-infected patients for AF. During follow-up, the incidence rates for the matched infected and non-infected patients were, respectively, 38.6 (95% CI 19.9 to 67.3) and 30.4 (29.1 to 31.8) per 1000 person-years for CHD; 69.6 (41.9 to 108.8) and 50.5 (48.9 to 52.2) per 1000 person-years for HF; 75.4 (48.3 to 112.2) and 35.5 (34.1 to 36.9) per 1000 person-years for stroke; and 34.7 (17.9 to 60.6) and 11.2 (10.4 to 12.0) per 1000 person-years for AF. Infected patients were significantly more likely to develop stroke (adjusted HR: 2.05, 95% CI 1.22 to 3.47; adjusted subdistribution HR: 1.94, 95% CI 1.15 to 3.26) and AF (3.29, 1.49 to 7.26; 2.74, 1.24 to 6.05) than their non-infected counterparts. CONCLUSIONS: S. pneumoniae infections elevate the risk of subsequent stroke and AF occurrence. These findings indicate that pneumococcal infections have short-term effects on patients’ health and increase their midterm to long-term susceptibility to serious cardiovascular events.
format Online
Article
Text
id pubmed-9639073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96390732022-11-08 Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study Nishimura, Naoaki Fukuda, Haruhisa BMJ Open Cardiovascular Medicine OBJECTIVES: To elucidate the risk of cardiovascular event occurrence following Streptococcus pneumoniae infection. DESIGN: Retrospective cohort study using a LIFE Study database. SETTING: Three municipalities in Japan. PARTICIPANTS: Municipality residents who were enrolled in either National Health Insurance or the Latter-Stage Elderly Healthcare System from April 2014 to March 2020. EXPOSURE: Occurrence of S. pneumoniae infection. PRIMARY OUTCOME MEASURES: Occurrence of one of the following cardiovascular events that led to hospitalisation after S. pneumoniae infection: (1) coronary heart disease (CHD), (2) heart failure (HF), (3) stroke or (4) atrial fibrillation (AF). RESULTS: S. pneumoniae-infected patients were matched with non-infected patients for each cardiovascular event. We matched 209 infected patients and 43 499 non-infected patients for CHD, 179 infected patients and 44 148 non-infected patients for HF, 221 infected patients and 44 768 non-infected patients for stroke, and 241 infected patients and 39 568 non-infected patients for AF. During follow-up, the incidence rates for the matched infected and non-infected patients were, respectively, 38.6 (95% CI 19.9 to 67.3) and 30.4 (29.1 to 31.8) per 1000 person-years for CHD; 69.6 (41.9 to 108.8) and 50.5 (48.9 to 52.2) per 1000 person-years for HF; 75.4 (48.3 to 112.2) and 35.5 (34.1 to 36.9) per 1000 person-years for stroke; and 34.7 (17.9 to 60.6) and 11.2 (10.4 to 12.0) per 1000 person-years for AF. Infected patients were significantly more likely to develop stroke (adjusted HR: 2.05, 95% CI 1.22 to 3.47; adjusted subdistribution HR: 1.94, 95% CI 1.15 to 3.26) and AF (3.29, 1.49 to 7.26; 2.74, 1.24 to 6.05) than their non-infected counterparts. CONCLUSIONS: S. pneumoniae infections elevate the risk of subsequent stroke and AF occurrence. These findings indicate that pneumococcal infections have short-term effects on patients’ health and increase their midterm to long-term susceptibility to serious cardiovascular events. BMJ Publishing Group 2022-11-04 /pmc/articles/PMC9639073/ /pubmed/36332949 http://dx.doi.org/10.1136/bmjopen-2021-059713 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Cardiovascular Medicine
Nishimura, Naoaki
Fukuda, Haruhisa
Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
title Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
title_full Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
title_fullStr Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
title_full_unstemmed Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
title_short Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
title_sort risk of cardiovascular events leading to hospitalisation after streptococcus pneumoniae infection: a retrospective cohort life study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639073/
https://www.ncbi.nlm.nih.gov/pubmed/36332949
http://dx.doi.org/10.1136/bmjopen-2021-059713
work_keys_str_mv AT nishimuranaoaki riskofcardiovasculareventsleadingtohospitalisationafterstreptococcuspneumoniaeinfectionaretrospectivecohortlifestudy
AT fukudaharuhisa riskofcardiovasculareventsleadingtohospitalisationafterstreptococcuspneumoniaeinfectionaretrospectivecohortlifestudy